Guangzhou Fu'erbo Biological Technology Co.,Ltd.

Firmenname:Guangzhou Fu'erbo Biological Technology Co.,Ltd.

Telefon:-

E-Mail:1536198927@qq.com

Nationalität:China

URL: https://www.chemicalbook.com/supplier/25444902/

Produkte insgesamt:10000

94 95 96 97 98 99 100

Produktkatalog

Human esophageaI smaII ce carcinoma ceIIIi ne estabI ish from mouse xenograft.
Giant ceII tumor ceIII ine
gIiobIastoma , GFAP and S- 100-positive , ACNU(a cance chemotherapY drug)-sensiti
gIioma , GFAP-positive , S-10 and NSE-negative
Human ceIIIine derived from human gIioma .
Human undifferentiated carcinoma ceIII ine fromfIoo of mouth (HeLa evidences observed) .
The ceIII ine deposited as a human acute monocYtic Ieukemia but manY data sho this ceIIIi ne is a subIi ne oft HeLa .
Iymphoma , maIignant, B-ceI non-Hodgkin 's , IgM kappa- producing
Human B ceIIIymphoma ce Ii ne with EBNA(-) . Ig D and I were expressed on the surface ofceIIs .
Acute IymphobIastoid Ieukemia (ALL) ceIIIine from human .
Human ceIIIi ne estabIished from patient with acute IymphobIastic Ieukemia .
Ieukemia , acute T IymphobIastic
Human T-IymphobIastic Ieukemia ceIII ine from impIanted tumor in Syrian hamster.
Ieukemia , acute B IymphobIa5tic
This ceIIIine posseses more mature characteristics than CMK-86 ceIIs .
This ceIII ine expresses GP II b/IIIa . Contains aI pha- gran uIe . Contains pIateIet peroxidase activity.
Mutant ceIII ine derived from human ALL ceIIIine , RPMI8402 .
Human myeIoma ceIIIi ne secreting Ig D .
Ki-1-positive T-ceIIIymphom ce III ine .
InterIeukin-6-dependent human myeIoma ceIIIi ne fro an agressive nonsecretory pIasma ceIIIeu kemia .
Human Hodgkin 's Iymphom ce IIIi ne of B-ce II origin .
SubIi ne of the HL60 having faster growth rate but the capabiIities of the differentiation by TpAor etc were decIi ned .
Iymphocyte , peri pheraI
estabIished as pIasmacytom but reveaIed as derivative o Jiyoye ceIII ine (Burkitt's Iymphoma)
The J KT-beta-deI ceIII ine isoIated fromthe Jurkat ceIIs{5011} by a ceII sorter a Iacksthe surface expression ofthe T-ceII receptor aIpha/beta/CD3 compIex.
Adriamycine resistant derivative of K562 ceIII ine .
B ceIIIeu kemia
AnoveI human Ieukemia ce Ii ne estabIished from a patie with chronic myeIogenous Ieukaemia (CML) in bIast crisis .
T ceIIIeu kemia
B ceIIIeu Iemia
mixed Ii neage Ieu kemia
myeIoid Ieu kemia secondarto ATL
myeIobIastic Ieukemia
Human Bukitt's Iymphoma , ALL-L3 ceIIIine . H LA- DR,CD19 and surface immunogIobuIin(mu , Iambda positive . Ig gene rearrangements observed .
Human acute B-ceII Iymphocytic Ieukemia ceIII in with two transIocations t(8;1 and t(14;18) .
Human mononucIear ceIIs w mu Iti pIe nucIeoIi from Iymphoma patient.
human myeIoma ceIIIi ne .
Ieukemia , acute myeIobIasti
Ieukemia , chronic myeIoid
Ieukemia , acute myeIoid
Ieukemia , acute myeIoid , subcIone of KY821
Ieukemia , acute non T IymphobIastic
Ieukemia , chronic megakaryobIastic, MEG-01 s derivative adapted to serum free medium
This ceIIIi ne is usefu I for studying the differentiation a maturation of megakaryocyt
foIIicuIar B ceIIIymphoma
B ceIIIymphoma (Burkitt typ
AmegakaryobIastic Ieukem ceIIIine from human acute myeIobIastic Ieukemia .
The ceIIs are IgD , IgM positive , hairy B-ceIIs from human maIignantIymphom patient.
Ieukemia , NK-Ii ke T ceIII ine
Human bone marrow mononucIear ceIIs derived from a patient having acute bi phenotypic Ieukemia .
SubcIone of the MY, human bone marrowmonon ucIear ce IIs .
SubcIone of the MYceIIs , human bone marrow mononuIcear ceIIs .
The CDRIII of this Ii ne has been sequenced .
Human ' nu II ' ceII fromALL c Ii ne .
I ia T
This ceIII ine produce interferon .
Iymph bIast, C ntaminati n RajiceIIs has been suspect
Human myeI gen us Ieukemia ceIII ine .
Ieukemia , acute myeI id , myeI id Ieukemia ceIIs , resp nsive t G-C5F and M C5Ff r gr wth
This ceIIIi ne is usefu I f r studying the differentiati n a maturati n fm n cytes .
Iymph ma , Burkitt's
Ph1 chr m s me-p sitive human acute Iymph bIastic Ieukemia ceIII ine .
Ahuman Iymph ma ceIIIi ne with t(11;14) chr m s me abn rmaIity.
estabIished fr mn rmaI bI d , IgM secreting
Human m n cytic ceIIIine expressing InterIeukin-2 recept r.
a GM-C5F dependent ceIIIi with an t8 , 21 chr m s me transI cati n estabu Iished fr ma patient attacked by acute myeI id Ieu kemia(AM
Human viII us Iymph ma B- ceIII ine fr mspIenic B-ceII Iymph ma .
Human HHV-8 negative maIignant effusi n Iymph m (DLBCL) .
Human B-ceIIIymph ma ce Ii ne with near-tripI id chr m s mes with t(14;18) and p53 gene p int mutati
Ieukemia , acute B IymphobIastic, dou bIe PhiIadeIphia chromosomes
Human hepatobIastoma ceI Ii ne from an infant.
Human hepatoma ceIIIi ne .
weII differentiated human hepato ceII uIar carcinoma c Ii ne .
Rhabdoid tumor of kidney (formerIy cIassified as wiI m tumor)
renaIIeiomyobIastoma
MaIignant rhabdoid tumor o the kidney ceIII ine .
Human renaI peIVis .
Human tumor ceIIIine from kidney. CIear ceII renaI carcinoma ceIII ine .
Human renaI carcinoma ceI Ii ne from kidney.
Human tumor ceIIIine from kidney. CIear ceII renaI carcinoma ceIII ine . The growth is extremeIy sIow.
Human renaI cancer ceIII ine metastasized to muscIe .
renaI ceII carcinoma
renaI carcinoma
B ceIIIeukemia ceIII ine
B ceIIIeukemia ceIII ine , Ig negative , ALL-L3 ceIII ine , t(8;22)(q24;q11) , hypercaIcemia , mRNA expre55ion of PTH rP
B ceIIIeukemia ceIII ine , AL L2 ceIII ine , hypercaIcemia
B ceIIIeukemia ceIII ine , AL L3 ceIII ine , t(8;14)(q24 . 1;q3
Human ceIIIine derived from erythrobIa5tic Ieukemia .
B ceII precur5or Ieu kemia
AnoveI human Ieukemia ce Ii ne e5tabIi5hed from bIa5t ceII5 of a patient attaked by myeIoperoxida5e-negative acute Ieukemia .
Human acute myeIoid Ieukemia ceIII ine with dominant negative mutation the C/EBPaIpha gene .
Human naturaI kiIIer ceIII ine with a p53 point mutation a5 modeI for p53-a55ociated Ieukemogene5i5 and a mod for differentiation of Nk/T ce II5 .
MegakaryobIastic Ieukemia ceIII ine derived from minim differentiated acute Ieukemi (AML-M0) with myeIoid/NK precursor phenotype .
Human mu ItipIe Ieukemia ce Ii ne with diverse myeIoid and/or megakaryobIastic characteristics
Bi phenotypic (B-ceII and myeIoid ceII features) Ieukemic ceI IIi ne .
Bi phenotypic (B-ceII and myeIoid ceII features)t(9;22 (q34;q11)-positive B-ceII precursor ceIIIi ne estabI ish from acute Ieukemia patient
Human diffuse Iarge B-ceII Iymphoma ceIIIi ne with two transIocations t(14;18)(q32; q21) and t(8;22)(q24;q11) .	2-(2-Methoxyethoxy)ethanol	C5H12O3
B-ceII precurrsor (BCP) acu IymphobIastic Ieukemia (AL ceIII ine . Derived from the same patient as NALM-37
B-ceII precurrsor (BCP) acu IymphobIastic Ieukemia (AL ceIII ine . Derived from the same patient as NALM-36
Ieukemia , acute monocytic, adriamycin-resistant derivat of NOMO-1

94 95 96 97 98 99 100